SprintRay adds intraoral scanner and compact chairside line at 3DNext
The dental technology company introduced a wireless scanner built for its ScanOS software, a compact print-wash-cure…
NFT Limited Releases RWAIX Protocol, Targets 90-Day Pilot
The company said the protocol is meant to let buyers, sellers, AI agents and robots verify identity, terms and…
HOZO Hobby Knife launches on Kickstarter with push-button blade changes
The Hong Kong toolmaker's new craft knife pairs a button-operated blade mechanism with a case that unfolds into a…
Parkinson's drug solengepras to be filed for approval after trial reports daily-living gains
Patients in the ARISE trial reported improvements in daily living and gained an average of 36 more minutes of "good"…
Guo Pei Costume Retrospective Opens in Hangzhou
The China National Silk Museum is showing roughly 200 haute couture pieces from four decades of Guo Pei's work.
Celltrion to present two ZYMFENTRA analyses at ACG 2026
Celltrion USA said the oral presentations cover subcutaneous versus intravenous infliximab in ileum-dominant Crohn's…
AnX Robotica Highlights FDA Documents on Capsule Reading Times
The company points to two separately conducted reader studies that reported lower mean review times for AI-assisted…
Tchah Sup Kim retrospective opens at Korean Cultural Center New York
The Korean artist's first posthumous retrospective brings more than 130 works and archival materials to the center's…
CITY JAM's Pat Villaceran Says Original Sound Is What AI Cannot Force
CITY JAM says its INDUSTRY.AIFF program works in the stretch between signing an artist and a finished record, as…
RingConn smart ring receives FDA 510(k) clearance for blood oxygen measurement
Shenzhen Ninenovo says its RingConn smart ring has cleared US regulatory review for non-invasive SpO2 measurement.
iQIYI reports higher daily viewing time during China's National Day holiday
The platform said average daily viewing time rose more than 12% over the October 1 to 7 holiday, with television…
Prifemilast beats apremilast on both endpoints in Phase 3 psoriasis trial, cAMPfield says
The company reported that its once-daily PDE4B inhibitor outperformed apremilast at Week 16 and is now being taken into…